Talis Biomedical (TLIS)
(Delayed Data from NSDQ)
$9.22 USD
+0.24 (2.67%)
Updated May 20, 2024 11:42 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TLIS 9.22 +0.24(2.67%)
Will TLIS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TLIS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLIS
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates
Halozyme Therapeutics (HALO) Q1 Earnings and Revenues Miss Estimates
TLIS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates
MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates
Other News for TLIS
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
Talis: Q1 Earnings Snapshot
Talis Biomedical Secures Interim CFO Amidst Corporate Changes
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Two new option listings and option delistings on February 26th